Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon

by D’Ambrosio, Roberta, Degasperi, Elisabetta, Aghemo, Alessio, Fraquelli, Mirella, Lampertico, Pietro, Rumi, Maria Grazia, Facchetti, Floriana, Grassi, Eleonora, Casazza, Giovanni, Rosenberg, William, Bedossa, Pierre, Colombo, Massimo
Published 2016

PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma

by Valenti, Luca, Motta, Benedetta Maria, Soardo, Giorgio, Iavarone, Massimo, Donati, Benedetta, Sangiovanni, Angelo, Carnelutti, Alessia, Dongiovanni, Paola, Rametta, Raffaela, Bertelli, Cristina, Facchetti, Floriana, Colombo, Massimo, Fargion, Silvia, Fracanzani, Anna Ludovica
Published 2013

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study

by Gardini, Andrea Casadei, Marisi, Giorgia, Faloppi, Luca, Scarpi, Emanuela, Foschi, Francesco Giuseppe, Iavarone, Massimo, Lauletta, Gianfranco, Corbelli, Jody, Valgiusti, Martina, Facchetti, Floriana, Corte, Cristina della, Neri, Luca Maria, Tamberi, Stefano, Cascinu, Stefano, Scartozzi, Mario, Amadori, Dino, Nanni, Oriana, Tenti, Elena, Ulivi, Paola, Frassineti, Giovanni Luca
Published 2016